Beacon Therapeutics

Transforming lives with pioneering ocular gene therapy

Beacon Therapeutics is an ophthalmic gene therapy company founded to save and restore the vision of patients with a range of prevalent and rare retinal diseases that result in blindness.

CEO Lance Baldo

Advent Contact  Dominic Schmidt

Private Companies
25 July 2024 in Beacon Therapeutics, Press Release, Private Companies

Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer

Press Release.   CEO Dave Fellows named non-Executive Chairman of the Board Executive appointments follow $170 million Series B fundraise London, UK and Cambridge, Mass., July 24, 2024 – Beacon…
Read More